Labcorp Holdings Inc. (LH)
Healthcare
Diagnostics & Research
307.40 $
-0.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Labcorp Holdings Inc. (LH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 446 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 276 | 580 | -30 | 561 | 277 | 777 | 19 | 621 | 387 | 614 | 192 | 446 | 1,638 | |
| 146 | 150 | 155 | 157 | 162 | 171 | 167 | 170 | 171 | 173 | 173 | 179 | 696 | |
| 34 | 27 | 32 | 31 | 27 | 27 | 33 | 34 | 29 | 30 | 32 | 35 | 126 | |
| 164 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -108 | 225 | -468 | 103 | -119 | 330 | -445 | 95 | -219 | 43 | -353 | -198 | -727 | |
| 105 | 167 | 134 | 128 | 116 | 112 | 126 | 78 | 107 | 124 | 121 | 132 | 483 | |
| -841 | -331 | -393 | -185 | -579 | -210 | -336 | -94 | -374 | -390 | -322 | -366 | -1,452 | |
| 64 | 61 | 62 | 60 | 61 | 60 | 62 | 60 | 60 | 59 | 61 | 59 | 239 | |
| -1,009 | 9.0 | -15 | -100 | -75 | -75 | -26 | -200 | -25 | -225 | -98 | -354 | -702 | |
| 90 | – | – | – | 1,380 | -400 | -1,000 | 0.0 | 0.0 | 0.0 | 750 | – | – | |
| -988 | -447 | -12 | -210 | 1,548 | -547 | -840 | -267 | -60 | -290 | 581 | -920 | -689 | |
| -1,203 | -191 | -438 | 166 | 1,252 | 1.4 | -1,149 | 278 | -49 | -66 | 449 | -839 | -506 | |
| 171 | 412 | -164 | 433 | 162 | 665 | -108 | 543 | 281 | 490 | 71 | 314 | 1,155 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.